Overview of Runxin Biotech at CPHI China 2026 Runxin Biotech will exhibit at CPHI China 2026 in Shanghai, presenting pharmaceutical, cosmetic, and food grades of sodium hyaluronate, chondroitin sulfate, and glucosamine. The portfolio includes biofermentation-derived chondroitin sulfate and multiple glucosamine forms. At the booth, the team will discuss customized molecular weight specifications, regulatory documentation support, stability data, and flexible MOQs for various applications. The event reflects ongoing quality advancements in China’s pharmaceutical ingredient sector.
READ MOREOverview of Runxin Biotech at Vitafoods Europe 2026 Runxin Biotech participated in Vitafoods Europe 2026 in Barcelona, showcasing pharmaceutical-grade sodium hyaluronate, chondroitin sulfate, and glucosamine. European buyers emphasized clean label credentials, regulatory documentation, batch-to-batch consistency, and supply chain traceability. Emerging application areas included GLP-1 companion nutrition, women’s health, and healthy aging. The event reinforced demand for technical partnership and pre-assembled regulatory support for EU market access.
READ MOREHere is a brief, plain-language overview of the article you provided, written in under 400 characters without any efficacy claims. Overview of Sodium Hyaluronate’s Hydration & Lubrication Mechanism Sodium hyaluronate is a long-chain polysaccharide that forms semi-rigid coils in water. Its negatively charged groups attract water molecules, creating a three-dimensional network. This network produces viscoelastic, shear-thinning fluids. High molecular weight variants remain on surfaces, while lower weights disperse differently. This behavior is concentration- and molecular-weight-dependent.
READ MORE
